The inaugural DC Health Innovation Summit united 175+ leaders to cement Washington, DC as a global powerhouse for health & life sciences.
The inaugural DC Health Innovation Summit, hosted by the DC Tech & Venture Coalition (DCTAV) on March 4, 2026, successfully united over 175 senior executives, investors, founders, and policymakers. The energy in the room was focused on a single mission: to strategically dismantle silos and establish Washington, DC as a premier global hub for the next wave of health and life sciences innovation.
The core message of the day was unambiguous: To successfully scale healthcare innovation, a company must prove a direct financial Return on Investment (ROI) that specifically solves the economic buyer's bottom-line metrics.
The discussions throughout the day crystallized into four critical insights for founders and investors navigating this highly regulated sector:
Regulation should be seen as a framework for building a defensible market position, not a roadblock. Embedding legal compliance into the full product lifecycle from day one is essential to avoid costly issues like False Claims Act or anti-kickback liability.
Innovations must identify their precise economic buyer, understand the specific financial metrics they are measured against, and construct a regulatory and reimbursement framework before seeking growth capital.
In healthcare, the most impactful role for artificial intelligence is to enhance human capacity. This means providing patients with clarity in their diagnoses and treatment options, and automating the tedious, repetitive tasks that burden clinical providers.
To sustain a thriving health tech economy, DC must focus on transforming its downtown into a vibrant, residential neighborhood with amenities. This is a core strategy for attracting and retaining the university and technical talent required to fuel the ecosystem.
The summit provided a comprehensive view of the landscape, from early-stage science to federal policy.
In healthcare, AI's most impactful role is to expand clinician capacity and provide clarity for patients, rather than replacing human care.
Speaker: Felipe Millon, OpenAI
The panel focused on bridging the gap between promising early-stage science and commercial viability, emphasizing the need for manufacturing scalability, patient access, and seamless clinical integration.
Speakers: Bryant Godfrey (Moderator), Partner, Foley Hoag; Carter Cliff, President, Agnos Therapeutics; Melissa Cohen, Founding Partner, Coral Health Advisors; Dr. Nawar Shara, Director, Medstar Health Research Institute Center for Biostatistics Informatics and Data Science
The second panel highlighted how federal pathways, such as the CMS ACCESS model, provide critical opportunities for digital health, while stressing the importance of interoperability and strategic planning around initial reimbursement rates.
Speakers: Jashaswi Ghosh (Moderator), Limited Partner, Holon Law Partners; Tommy Barletta, Co-Founder & Managing Partner, Aldis Institutional; Jennifer Everrett, Partner, Alston and Bird; Caroline Farrell, Counsel, Foley Hoag; Tricia Lee, Chief, Digital Health Strategies - Assistant Secretary for Technology Policy, U.S. Department of Health & Human Services (HHS)
This session discussed how DC is uniquely positioned to lead highly regulated tech, urging founders to leverage their proximity to policymakers to co-create market playbooks.
Speakers: Kevin Morgan (DCTAV) and Keith Camhi (Techstars DC)
This panel emphasized a shift in the funding environment toward risk mitigation, demanding clear, immediate paths to profitability; cybersecurity and robust data integrity were noted as non-negotiable deal-killers.
Speakers: Michelle Boquiren Urben (Moderator), Managing and General Partner, Synergos Fund; Deanna Angello, Life Sciences & HealthTech Executive Council, Springboard Enterprises; Bryce Arruda, Managing Director, Life Sciences Deal Advisory & Strategy, KPMG; Sriya Srinath, Principal, Morgan Health Ventures, JPMorganChase; Emily Zhen, Principal, Zeal Capital Partners
Mr. Posnack highlighted the ONC's role as the "Front Door to HHS," stressing the strict enforcement of rules and multimillion-dollar penalties against information blocking to drive nationwide data sharing.
Speaker: Steven Posnack, ONC/HHS
Four innovative companies showcased their work and outlined their needs for strategic partners and capital:
The success of this first annual summit firmly established the momentum needed to build Washington, DC into a global hub for health innovation - a mission made possible by the collective commitment of organizers, sponsors, and the community.
Organized by: DC Tech and Venture Coalition (DCTAV)
Sponsors & Partners: NovaVector Holdings, Foley & Hoag, and Washington DC Economic Partnership (WDCEP)
